SCHEMBL2015779

SCHEMBL2015779

NCCc1cc(Cl)c2cccnc2c1-c1cccc(F)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 1/20 0.44
TAAR1 Q96RJ0 2/20 0.41
SYK P43405 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
CCR1 P32246 1/20 0.40
CCR8 P51685 1/20 0.40
MMP14 P50281 3/20 0.39
KDM4E B2RXH2 5/20 0.39
LMNA P02545 3/20 0.39
HSP90AA1 P07900 3/20 0.39
MAPT P10636 3/20 0.39
HTT P42858 3/20 0.39
KMT2A Q03164 3/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
TDP1 Q9NUW8 3/20 0.39
RAB9A P51151 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
CDC7 O00311 1/20 0.39
ROCK2 O75116 1/20 0.39
MAP4K4 O95819 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2014788 0.89 TAAR1 (0.43) PIK3CDTAAR1SYKL3MBTL1KDM4E
SCHEMBL2013016 0.86 TAAR1 (0.41) PIK3CDTAAR1SYKCCR1CCR8
SCHEMBL12491178 0.85 BCL2 (0.47) PIK3CDTAAR1SYKKDM4ECYP3A4
SCHEMBL2017434 0.85 TAAR1 (0.40) PIK3CDTAAR1SYKKDM4ECDC7
SCHEMBL2013332 0.83 MAP4K4 (0.42) PIK3CDTAAR1SYKKDM4ECDC7
SCHEMBL2015005 0.82 PIK3CD (0.44) PIK3CDL3MBTL1CCR1CCR8MMP14
SCHEMBL2012666 0.82 TAAR1 (0.47) TAAR1KMT2AHTR1A
SCHEMBL2015741 0.81 L3MBTL1 (0.44) L3MBTL1CCR1CCR8MMP14KDM4E
SCHEMBL2011259 0.79 TAAR1 (0.43) PIK3CDTAAR1SYKCCR1CCR8
SCHEMBL2015154 0.79 TAAR1 (0.41) TAAR1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011075630-A1 SUBSTITUTED FUSED ARYL AND HETEROARYL DERIVATIVES AS PI3K INHIBITORS INCYTE CORPORATION (US) 2011-06-23 WO disclosed